AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05042583 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Stellate ganglion block
Description: The probe direction was 30-45 degrees from the sagittal plane of the neck. The anterior nodules of the transverse process of the sixth cervical vertebra were displayed. The important anatomical structures were distinguished, and the internal carotid artery and longus cervical muscle were observed. A 25G, 6cm puncture needle was used with the tip beveled downward, and the needle path and tip were shown under ultrasound. The tip reached the high-echo sieve structure between the carotid artery and longus cervical muscle, and the drug solution was injected after withdrawal without blood and gas . The experimental group was injected with 6ml 0.5% ropivacaine.
Study NCT05042583 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: The probe direction was 30-45 degrees from the sagittal plane of the neck. The anterior nodules of the transverse process of the sixth cervical vertebra were displayed. The important anatomical structures were distinguished, and the internal carotid artery and longus cervical muscle were observed. A 25G, 6cm puncture needle was used with the tip beveled downward, and the needle path and tip were shown under ultrasound. The tip reached the high-echo sieve structure between the carotid artery and longus cervical muscle, and the drug solution was injected after withdrawal without blood and gas . The experimental group was injected with 6ml 0.5% ropivacaine.
Study NCT05144139 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 mRNA vaccine
Description: Intramuscular injection, COVID-19 mRNA vaccine/placebo, 21 days interval
Study NCT05144139 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: COVID-19 mRNA vaccine
Description: Intramuscular injection, COVID-19 mRNA vaccine/placebo, 21 days interval
Study NCT05187819 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: predictive value of a blood test
Description: Evaluation of the clinical value of a new blood based test for diagnosis of Alzheimer's disease in a general practice population.
Study NCT05187819 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: predictive value of a blood test
Description: Evaluation of the clinical value of a new blood based test for diagnosis of Alzheimer's disease in a general practice population.
Study NCT06340035 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS
Description: The TENS group is subjected to transcutaneous current. Two surface electrodes are inserted at the level of the superior gluteal and inferior gluteal nerve tract. A protocol of 10 stimulations x 10 seconds of stimulations x 10 times is performed with a 10 second rest between each repetition. A maximum contraction evoked without pain is sought.
Study NCT06340035 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Percutaneous Peripheral Nerve Stimulation
Description: In the pPNS group, the superior gluteal nerve and inferior gluteal nerve are stimulated percutaneously. The nerves are localized at an ultrasound-guided level and with respect to the vascular-nervous package two acupuncture needles are inserted, one for each nerve. The stimulation is the same as the TENS group: 10 stimulations x 10 times x 10 seconds, evoking the maximum contraction without pain.
Study NCT06089720 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zinc oxide nanoparticle coated orthodontic molar tubes (experimental)
Description: nine orthodontic patients each one will receive 2 coated zinc oxide nanoparticle molar tubes in split-mouth manner and will assess for antimicrobial effect on s. mutans \& lactobacillus after two weeks, in addition to evaluation of bond failure rate after three months.
Study NCT06089720 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: orthodontic molar tubes (control)
Description: nine orthodontic patients each one will receive two uncoated molar tubes in split-mouth manner and will assess for antimicrobial effect on S. mutans \& lactobacillus after two weeks, also, evaluation of the bond failure rate after three months period.
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vanzacaftor
Description: Tablets for oral administration.
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vanzacaftor Placebo
Description: Placebo for oral administration.
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vanzacaftor Placebo
Description: Placebo for oral administration.
Study NCT04993547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Parent and peer presence
Description: Does the presence of fellow pupils and parents improves a pupil's resistance to undergo a nasopharyngeaal swab test?
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: Tablets for oral administration.
Study NCT04993547 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Parent and peer presence
Description: Does the presence of fellow pupils and parents improves a pupil's resistance to undergo a nasopharyngeaal swab test?
Study NCT06357897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local PEG4000
Description: PEG-Chula is developed from PEG 4000 used at King Chulalongkorn Memorial Hospital with added sweetener and flavours. Children will be given PEG-Chula at a dose of 0.5 - 1 g/kg/day.
Study NCT06357897 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Commercial PEG4000
Description: For commercial PEG, We use Forlax as the control group. Children will be given Forlax at a dose of 0.5 - 1 g/kg/day.
Study NCT04108286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1-DAY ACUVUE MOIST
Description: TEST
Study NCT04108286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DAILIES AQUA COMFORT PLUS
Description: CONTROL
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin Placebo
Description: Tablets for oral administration.
Study NCT05867147 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin Placebo
Description: Tablets for oral administration.
Study NCT06046976 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: piesosurgical extraction
Description: exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
Study NCT04803149 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooled Radiofrequency
Description: Delivery of energy to ablate sensory nerves via cooled radiofrequency probe
Study NCT04803149 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Radiofrequency
Description: Delivery of energy to ablate sensory nerves via standard or conventional radiofrequency probe
Study NCT06046976 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: piesosurgical extraction
Description: exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
Study NCT05557526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expectation optimization
Description: A short (2-5 min) verbal intervention will be createad individually based on the expectation of the patient towards the procedure.
Study NCT06046976 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional extraction
Description: exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
Study NCT06046976 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional extraction
Description: exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SBT6050
Description: Dose range of 0.45 to 0.6 mg/kg by subcutaneous (SC) injection in 21-day cycles
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab deruxtecan
Description: 5.4 mg/kg by intravenous (IV) infusion in 21-day cycles
Study NCT04828980 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oculus Quest: TRIPP
Description: This is a VR experience that focuses on meditation and mindfulness
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tucatinib
Description: 300 mg by mouth (PO) twice daily (BID)
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab
Description: 8 mg/kg loading dose (first dose), then 6 mg/kg maintenance dose (subsequent doses) IV infusion in 21-day cycles
Study NCT04828980 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oculus Quest: Angry Birds
Description: This is an active gaming VR experience that utilizes controllers to aim and launch objects at targets.
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Description: 1000 mg/m2 PO BID for 14 days of each 21-day cycle
Study NCT05091528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab deruxtecan
Description: 6.4 mg/kg by IV infusion in 21-day cycles
Study NCT04698356 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auditory-cognitive training paradigm
Description: The investigators developed an American English version of the Nottingham (UK) PLUS training paradigm in which listeners are asked to focus and listen to one speaker while ignoring another speaker. The paradigm is designed to optimally enhance the possibility of benefit: an adaptive procedure is employed in order to train each individual at their own level and to make the task challenging. A short-term memory component was also added to the original training paradigm, to enhance the cognitive skills of our participants. To provide maximal speech-in-noise benefit for older, normal-hearing adults, a validation of our new training materials is required. The investigators will evaluate this in young, normal-hearing adults (18-30 years) by studying our outcome measure (speech reception threshold) for the different sentence-scenarios and test-retest sessions.
Study NCT03766178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab + SHR-1210
Description: SHR-1210: 200 mg/time, intravenous injection, q2W continuous medication, a course of treatment needs 28 days. The cumulative longest medication period is 2 years.~Nimotuzumab: 200 mg/time, intravenous injection, administered on the 1st and 8th days of each cycle, every 2 weeks is one cycle.
Study NCT04415541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychodynamic Psychotherapy
Description: Intensive psychotherapy that is psychodynamically oriented.
Study NCT04415541 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Conventional treatment offered in the community.
Study NCT05148312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide Inhalant Product
Description: Single-dose of budesonide solution administered by nebulization.
Study NCT05148312 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Budesonide Inhalant Product
Description: Single-dose of budesonide solution administered by nebulization.
Study NCT05572502 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: plant-based diet
Description: For the duration of the study, this arm will: follow a low-fat vegan diet; weigh themselves weekly, and get fasting bloodwork before, during and after the study
Study NCT06445998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: task oriented training
Description: Task-oriented training program: \[For study group\] Rocker board training Wobble board training Sit to stand Walk five steps forward Upstairs and downstairs three steps
Study NCT06445998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: task oriented training
Description: Task-oriented training program: \[For study group\] Rocker board training Wobble board training Sit to stand Walk five steps forward Upstairs and downstairs three steps
Study NCT06538688 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic extrusion of the impacted mandibular third molar by using the maxillary miniscrew and cross arch elastic power chain as a temporary anchorage device before extraction
Description: Orthodontic extrusion of the impacted mandibular third molar of high-risk for nerve injury using maxillary TAD.
Study NCT05049148 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Platelet count in excised tumors
Description: Tumors excised in patients requirering a brain or medullary surgery will be assess to determine their platelet count.
Study NCT05981638 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: group WM
Description: Patients were given 5ml/kg dose of water and patients were mobilized.
Study NCT05981638 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: group WR
Description: Patients were given 5ml/kg dose of water and patients were rest.
Study NCT05981638 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Group AR
Description: Patients were given 5ml/kg dose of apple juice and patients were rest.
Study NCT05981638 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Group AM
Description: Patients were given 5ml/kg dose of apple juice and patients were mobilized.
Study NCT06423430 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham-stimulation
Description: Sham-stimulation
Study NCT06423430 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active-stimulation
Description: Active DBS
Study NCT06478498 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Necator americanus L3 larvae
Description: Necator americanus L3 larvae
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Description: Trilaciclib administered IV over 30mins prior to chemotherapy on Day 1 and Day 8 of each 21-day cycle.
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered IV over 30mins prior to chemotherapy on Day 1 and Day 8 of each 21-day cycle.
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine administered IV on Day 1 and Day 8 of each 21-day cycle.
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine administered IV on Day 1 and Day 8 of each 21-day cycle.
Study NCT06505252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enoscopic Myringoplasty
Description: general anesthesia. A single surgeon will perform all surgeries.~* A small incision in the rim of ear lobule on the same side of the operated ear, a small piece of adipose tissue will be removed according to the experience of the surgeon.~* Using 0 angulation endoscope visualization, the edges of the perforation will be refreshed and deepithelialized with a sharp Rosen's needle~* sponge gel (Gelfoam) will pushed through TM perforation into the middle ear to support the graft and to avoid its medialization~* the previously removed fat graft will be inserted through the perforation adjusted so most of the fat piece lying medial to the perforation and small part laterally in patients group A: 0.5 mL of HA vial will be injected directly over the fat graft and the TM remnant. After 5 minutes small gelfoam pieces soaked in 0.5 mL of HA vial will applied over the fat in patients group B PRPG was inserted into the external auditory canal on the outer face of the TM remnant and fat
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin administered IV on Day 1 and Day 8 of each 21-day cycle.
Study NCT04799249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin administered IV on Day 1 and Day 8 of each 21-day cycle.
Study NCT05413408 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education and contact
Description: The intervention consists of three phases, including investigative learning activity (this section will last about one week), higher-order thinking activity (this section will last about two hours), collaborative activity (this section will last about two hours). Both the intervention group and the control group will be interns in the hospital simultaneously. The study outcomes include nursing students' knowledge, attitude, and behavioral intentions regarding stigma towards schizophrenia. The intervention effect will be evaluated by the researcher, comparing results between and within the two groups from baseline (T0) to immediately after first and second session intervention (T1), immediately after third session intervention (T2), and three months follow-up (T3).~The control group only has one session and will be given a book of schizophrenia knowledge, and they will be asked to finish reading it in four weeks.
Study NCT05413408 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and contact
Description: The intervention consists of three phases, including investigative learning activity (this section will last about one week), higher-order thinking activity (this section will last about two hours), collaborative activity (this section will last about two hours). Both the intervention group and the control group will be interns in the hospital simultaneously. The study outcomes include nursing students' knowledge, attitude, and behavioral intentions regarding stigma towards schizophrenia. The intervention effect will be evaluated by the researcher, comparing results between and within the two groups from baseline (T0) to immediately after first and second session intervention (T1), immediately after third session intervention (T2), and three months follow-up (T3).~The control group only has one session and will be given a book of schizophrenia knowledge, and they will be asked to finish reading it in four weeks.
Study NCT05899140 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clindamycin
Description: Clindamycin will be administered at a dose of 450 mg TDS (oral) or 10 mg/kg/dose QID iv (maximum 600mg QID iv) for a maximum of 7 days
Study NCT05899140 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Standard of care
Study NCT05899140 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care
Study NCT04557540 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Therapy
Description: Receive The WORD lifestyle CER weight loss intervention
Study NCT04557540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04557540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05073406 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altitude exposure in hypobaric normoxic condition
Description: Altitude exposure with oxygen supplementation to achieve normoxia at altitude
Study NCT05073406 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Altitude exposure in hypobaric hypoxic condition
Description: Altitude exposure with air supplementation to obtain a sham comparator arm
Study NCT05384808 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Psychotherapy
Description: Participants receive a standard psychotherapy session with no dog being present.
Study NCT05384808 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Canine-assisted psychotherapy with dog actively integrated.
Description: A dog is present and actively integrated into the therapeutic narrative.
Study NCT04557540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short-Term Fasting
Description: Receive Fasting WORD intermittent fasting weight loss intervention
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions every 12 hour (BID) over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered as oral suspensions BID over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions daily (QD) over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered as oral suspensions QD over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions every QD over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions QD over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions every 12 hour (BID) or everyday (QD) over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered as oral suspensions every 12 hour (BID) or everyday (QD) over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07328948
Description: PF-07328948 will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days
Study NCT05807490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered as oral suspensions every 12 hour (BID) or daily (QD) over 14 days
Study NCT05384808 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Canine-assisted psychotherapy with dog passively integrated.
Description: A dog is present but not actively integrated into the therapeutic narrative.